We therefore examined the relative essentiality of BCL2 and MCL1 towards MM cell survival by analyzing data from several CRISPR/Cas9 loss-of-function genetic screens in the CancerDep Map database. The gene discussed is BCL2; the disease is Miyoshi myopathy.